SWAV

Investor Moves

Name	Value	Action	Change	Price	Current Price
BlackRockInvestor $-1.2B ExitQ2 2024 $1.2B -- --
Ken GriffinCitadel Advisors $-199.8M ExitQ2 2024 $200M -- --
Steven CohenPoint72 $-103.1M ExitQ2 2024 $103M -- --
PRIMECAP ManagementInvestor $-90.1M ExitQ2 2024 $90M -- --
Baillie GiffordInvestor $-74.3M ExitQ2 2024 $74M -- --
Baillie GiffordInvestor $-74.3M ExitQ2 2024 $74M -- --

News

globenewswire.comRubicon Point Partners Acquires Shockwave Medical Headquarters Campus in Santa Clara, Californiaglobenewswire.comMay 14

Trade SWAV

About ShockWave Medical, Inc.

ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.

CEO: Douglas E. Godshall
IPO Date: Mar 7, 2019

Market Data

Open: $334.85
High: $334.90
Low: $334.75
Volume: 3.9M
Avg Volume: 1.3M
52W High: $334.90
52W Low: $157.00

Valuation

Market Cap: $13B
Enterprise Value: $13B
Dividend Yield: 0.00%

Financials

Free Cash Flow: $165M
Revenue: $730M
Net Income: $147M
Cash: $328M
Debt: $771M

Events

EarningsMay 6

EPS est. 0.98 · actual 1.44